SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Alm Albert) "

Sökning: WFRF:(Alm Albert)

  • Resultat 1-10 av 96
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  • Alm, Albert (författare)
  • Effects of norepinephrine, angiotensin, dihydroergotamine, papaverine, isoproterenol, histamine, nicotinic acid, and xanthinol nicotinate on retinal oxygen tension in cats
  • 1972
  • Ingår i: Acta Ophthalmologica. - : Wiley. - 0001-639X .- 1755-375X. ; 50:5, s. 707-719
  • Tidskriftsartikel (refereegranskat)abstract
    • The oxygen tension in the vitreous body close to the retina, PvrO2, was determined continuously in cats. The effects on PvrO2 of intraarterial injections of various vasoactive drugs were determined. The vasoconstrictors norepinephrine, angiotensin and dihydroergotamine did not change PvrO2 in five cats. The same result was obtained with the vasodilators isoproterenol, histamine and xanthinol nicotinate in five cats, and with nicotinic acid in six cats, while papaverine invariably increased PvrO2 in seven cats when injected intraarterially and in two cats when injected intravenously. It is suggested that the ability to penetrate the blood-retinal barrier may play an important role in determining the effect of vaso-active drugs on retinal blood flow.
  •  
4.
  •  
5.
  •  
6.
  • Alm, Albert, et al. (författare)
  • Five-year, Multicenter Safety Study of Fixed-combination Latanoprost/Timolol (Xalacom) for Open-angle Glaucoma and Ocular Hypertension
  • 2011
  • Ingår i: Journal of glaucoma. - 1057-0829 .- 1536-481X. ; 20:4, s. 215-222
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose: To evaluate the safety of fixed-combination latanoprost/timolol (Xalacom) in patients requiring additional intraocular pressure (IOP) reduction over 5 years. Methods: This phase 3b, open-label, multicenter study included prostaglandin-naive participants with open-angle glaucoma or ocular hypertension insufficiently responsive to beta-blockers and requiring additional IOP reduction. Participants were evaluated at eleven 6-month visits. A masked assessor evaluated iris/eyelash changes at baseline and 12, 36, and 60 months. Increased iris pigmentation incidence was compared with a historic control from a similarly designed study evaluating latanoprost. Ocular and systemic adverse events were recorded. Results: Among 828/974 treated participants with assessable iris photographs, 233 (28.1%) developed increased iris pigmentation versus 127/380 (33.4%) in the historic controls. Participants with mixed eye colors exhibited greater susceptibility to overall increased iris pigmentation (85.8% in both studies). In this study, most participants (80.3%) with increased iris pigmentation developed only a weak increase. Eyelash changes were seen in 58.1% of participants and darkening of the eyelids in 5-6%; 14.1% experienced a serious adverse event. Adverse events resulted in treatment withdrawal in 133 (13.7%) participants. Most were nonserious ocular adverse events, about half of them ocular irritation. Only 3 of 13 serious systemic adverse events were considered to be drug related by the investigator. Mean IOP reductions were stable over 5 years. Conclusions: After 5 years, more than 70% of participants treated with fixed-combination latanoprost/timolol had no increased iris pigmentation. The fixed combination is safe and well tolerated for long-term treatment in patients with open-angle glaucoma or ocular hypertension.
  •  
7.
  •  
8.
  •  
9.
  • Alm, Albert (författare)
  • Optic nerve and choroidal ciruculation: Physiology.
  • 1998
  • Ingår i: Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma.. - : I O Haeflger, J Flammer, Lippincott, Raven, Philadelphia. ; , s. 34-
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
10.
  • Alm, Albert (författare)
  • Phase 3 studies with latanoprost.
  • 1998
  • Ingår i: Prostaglandins in Ophthalmology. ; , s. 87-
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 96
Typ av publikation
tidskriftsartikel (66)
bokkapitel (8)
doktorsavhandling (7)
annan publikation (5)
recension (4)
bok (3)
visa fler...
forskningsöversikt (2)
rapport (1)
visa färre...
Typ av innehåll
refereegranskat (67)
övrigt vetenskapligt/konstnärligt (28)
populärvet., debatt m.m. (1)
Författare/redaktör
Alm, Albert (83)
Lindén, Christina (13)
Mäepea, Olav (9)
Nilsson, Siv (8)
Bjärnhall, Gunilla (8)
Tomic, Lidija (8)
visa fler...
Sperber, Göran (7)
Bergquist, Jonas (6)
Heijl, Anders (6)
Maepea, Olav (6)
Bengtsson, Boel (5)
Eriksson, Urban (5)
Henningsson, Ragnar (4)
Lundquist, Ingmar (4)
Alm, Per (4)
Larsson, Eva (4)
Camras, Carl B (4)
Calissendorff, Berit (4)
Botling Taube, Ameli ... (4)
Bergström, Anders (3)
Linden, C (3)
Lambrou, George (3)
Percicot, Christine (3)
Eckerlund, Ingemar (3)
Hardenborg, Emilia (3)
Salehi, S Albert (2)
Kämpe, Olle (2)
Nilsson, Lena (2)
Rönnblom, Lars (2)
Aquilonius, Sten-Mag ... (2)
Lindblom, Bertil (2)
Ståhle, Elisabeth (2)
Hällgren, Roger (2)
Ekström, Curt (2)
Salehi, Albert (2)
Venge, Per (2)
Alm, Håkan (2)
Wetterhall, Magnus (2)
Westermark, Per (2)
Vahlquist, Anders (2)
Andersson, Marit (2)
Wiklund, Lars (2)
Vogel, Katja (2)
Holmström, Gerd (2)
Alm, Albert, Profess ... (2)
Sperber, G.O. (2)
Hanrieder, Jörg (2)
Konzer, Anne (2)
Jimenez, Javier (2)
Mosén, Henrik (2)
visa färre...
Lärosäte
Uppsala universitet (81)
Umeå universitet (9)
Lunds universitet (9)
Karolinska Institutet (6)
Linköpings universitet (3)
Chalmers tekniska högskola (3)
visa fler...
Göteborgs universitet (2)
Luleå tekniska universitet (1)
Stockholms universitet (1)
VTI - Statens väg- och transportforskningsinstitut (1)
visa färre...
Språk
Engelska (82)
Odefinierat språk (9)
Svenska (5)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (30)
Naturvetenskap (3)
Samhällsvetenskap (3)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy